socalTechnews
Log in | Join | Subscribe

Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•

    Search News
    Monday, January 28, 2008

    Phenomix Files For IPO
    San Diego-based Phenomix said in a filing with the SEC Friday that it is looking to raise up to $86.25M in an IPO on the NASDAQ Global Market. The firm, which is looking to list as "PHMX" on the exchange, develops biopharmaceuticals focused on treatment of Type 2 diabetes, along with compounds for treatment of hepatitis C infections. The IPO is being underwritten by Morgan Stanley, Credit Suisse, Oppenheimer & Co., and Pacific Growth Equities. Phenomix is venture backed by JP Morgan FUnds, Nomura Phase4 Ventures, Delphi Funds, Alta Partnres Funds, Sofinnova Funds, Novartis Funds, Baker Brothers Funds, Bay City Capital, and CMEA, among others.
    posted on Monday, January 28, 2008

    Related companies:
    Phenomix

    Related stories:
    > Phenomix Gets $75M In Deal With Forest Labs
    > Phenomix Drops IPO Bid
    > Phenomix Raises $55M Series C
    > Phenomix Finds $40M Series B Funding
    > Bluebeam Launches CAD Conversion Program

    RSS subscri be via emailEmail Twitter


    Previous news:

     Monday, July 6, 2009
    Thursday, July 2, 2009
    Wednesday, July 1, 2009
    Tuesday, June 30, 2009
    Monday, June 29, 2009